Summary:
To address drug shortages and concerns about quality, industry experts say Congress should consider steps such as improving hospital incentives and revising purchasing contracts.
Mounting drug shortages and supply chain vulnerabilities are putting patient care at risk in hospitals across the nation. As experts sound the alarm in Congress, questions grow about the safety, cost, and reliability of vital medicines. What concrete steps can policymakers and industry leaders take to secure America’s pharmaceutical future? Read on to discover the proposals and debates shaping the path forward.
Source: Senate Committee Examines Ways to Strengthen the Supply Chain for Hospital Drugs, Nick Hut, HFMA, October 13,2025; https://www.hfma.org/operations-management/senate-committee-examines-ways-to-strengthen-the-supply-chain-for-hospital-drugs/ .
Topics
Quality Improvement
Healthcare Process
Environmental Influences
Related
“I Felt Violated”: What One Patient Complaint Taught Me About AI in the Exam RoomThe ER as America’s Mirror: 37 Years on the Front Lines with Dr. Louis ProfetaLabor and Delivery Coverage Models in a Changing Coding Environment: Implications for Coverage Economics, Compensation Design, and GovernanceRecommended Reading
Quality and Risk
Labor and Delivery Coverage Models in a Changing Coding Environment: Implications for Coverage Economics, Compensation Design, and Governance
Strategy and Innovation
The Shadow Economy of Toxic Leadership in Healthcare
Strategy and Innovation
Toxic Followership and Leadership: The Hidden Threat to Organizational Success